山东新华医疗器械股份有限公司关于2021年股权激励计划第三期限制性股票解锁暨上市公告

Core Viewpoint - The announcement details the unlocking and listing of restricted stocks under the 2021 stock incentive plan of Shandong Xinhua Medical Instrument Co., Ltd, with 2,282,513 shares set to be released on February 24, 2026 [2][4][18]. Group 1: Stock Incentive Plan Overview - The stock type being listed is part of the stock incentive plan, with a total of 2,282,513 shares to be unlocked [2][3]. - The third phase of the restricted stock under the 2021 incentive plan is being unlocked, with the unlocking date set for February 24, 2026 [4][16]. Group 2: Approval and Implementation Process - The stock incentive plan was approved during the board meeting on November 24, 2021, with independent directors providing their opinions [5][6]. - The plan underwent necessary public disclosures and received approvals from relevant authorities, including the State-owned Assets Management Unit [8][9]. Group 3: Unlocking Conditions and Details - The unlocking conditions for the third phase have been met, as confirmed by the board, allowing 324 eligible participants to unlock a total of 2,282,513 shares, which represents approximately 0.38% of the company's total share capital [17][20]. - The specific conditions for unlocking include performance metrics that align with the company's strategic goals [16]. Group 4: Stock Listing and Transfer Restrictions - The shares will be listed for trading on February 24, 2026, with specific transfer restrictions for directors and senior management during their tenure and for six months post-departure [18][19]. - The company will retain rights to any profits made from shares sold within six months of purchase or sale by directors and senior management [18]. Group 5: Independent Opinions and Legal Compliance - Independent directors have expressed that the unlocking process complies with relevant regulations and does not harm the interests of the company or its shareholders [20]. - Legal opinions confirm that all necessary approvals and procedures have been followed for the unlocking of shares [21].

SHINVA-山东新华医疗器械股份有限公司关于2021年股权激励计划第三期限制性股票解锁暨上市公告 - Reportify